These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 134754)

  • 21. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
    Dyer DC
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP) on successive sensory discrimination behavior maintained by electrical stimulation of the brain reinforcement in the rat.
    Vincent JH; Lenzer II
    Psychol Rep; 1976 Jun; 38(3 Pt 2):1083-92. PubMed ID: 935303
    [No Abstract]   [Full Text] [Related]  

  • 23. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus properties of the hallucinogenic agent DOM.
    Young R; Glennon RA; Rosecrans JA
    Commun Psychopharmacol; 1980; 4(6):501-6. PubMed ID: 7297054
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice.
    Yamamoto T; Ueki S
    Eur J Pharmacol; 1975; 32(02):156-62. PubMed ID: 1149803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin is involved in the psychostimulant and hypothermic effect of 4-methylamphetamine in rats.
    Rubio M; López-Arnau R; Pubill D; Escubedo E; Camarasa J
    Neurosci Lett; 2015 Mar; 590():68-73. PubMed ID: 25641130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
    Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
    [No Abstract]   [Full Text] [Related]  

  • 31. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
    Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
    NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
    [No Abstract]   [Full Text] [Related]  

  • 32. Discriminative stimulus properties of MDA analogs.
    Glennon RA; Young R; Rosecrans JA; Anderson GM
    Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
    Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1981 Oct; 15(4):659-62. PubMed ID: 7291270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of brain serotonin in apomorphine-induced hypothermia.
    Grabowska M; Michaluk J; Antkiewicz L
    Eur J Pharmacol; 1973 Jul; 23(1):82-9. PubMed ID: 4270157
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of zotepine on head-twitch induced by L-5-hydroxytryptophan, mescaline and 2,5-dimethoxy-4-methylamphetamine in mice and rats.
    Yamamoto T; Tazoe N; Ueki S; Shimomura K; Satoh H; Mori J
    Jpn J Pharmacol; 1983 Apr; 33(2):319-25. PubMed ID: 6136619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.
    Rasmussen K; Glennon RA; Aghajanian GK
    Eur J Pharmacol; 1986 Dec; 132(1):79-82. PubMed ID: 3816969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
    Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
    Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
    [No Abstract]   [Full Text] [Related]  

  • 40. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP; Handa A; Bindal MC; Singh P
    Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.